Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel

Articles

July 8, 2018

Immatics Enters Strategic Partnership With Genmab July 8, 2018

Immatics Biotechnologies GmbH recently announced it has entered into a research collaboration and license agreement with Genmab A/S to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancer indications.

May 31, 2018

INTEGRATED DELIVERY SYSTEMS – The Value of an Integrated System for Combination Products May 31, 2018

Theresa Bankston, PhD, says the fact that many of these therapies are designed for home delivery by patients or caregivers via subcutaneous injection, combined with increasing complexity of longer-acting formulations, larger injection volumes, and longer injection durations, has raised the bar for seamless injection delivery technology.

September 5, 2017

Rexahn Pharmaceuticals Receives New US Patent September 5, 2017

Rexahn Pharmaceuticals, Inc. recently announced that the United States Patent and Trademark Office has issued US Patent No. 9,744,167, Nanoparticulate...

Company Profiles

December 1, 2023

Lyophilization Technology, Inc.

Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...
December 1, 2023

CycloLab Cyclodextrin Research & Development Ltd.

CycloLab Cyclodextrin Research & Development Ltd. E: commerce@cyclolab.hu W: cyclolab.hu LinkedIn: https://www.linkedin.com/company/10040240 For more than 30 years, Cyclolab Ltd. has been involved in...